Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.95 USD
Change Today -0.05 / -2.50%
Volume 3.8K
CATS On Other Exchanges
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

catasys inc (CATS) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/7/15 - $2.45
52 Week Low
05/28/14 - $1.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CATASYS INC (CATS)

Related News

No related news articles were found.

catasys inc (CATS) Related Businessweek News

No Related Businessweek News Found

catasys inc (CATS) Details

Catasys, Inc. provides specialized healthcare management services to health plans and other third party payors through a network of licensed and company managed healthcare providers. It offers OnTrak integrated substance dependence solutions to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak substance dependence programs include medical and psychosocial interventions, a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services. Its OnTrak program includes various components, including member identification and engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2000 and is based in Los Angeles, California.

44 Employees
Last Reported Date: 03/31/15
Founded in 2000

catasys inc (CATS) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $450.0K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $370.3K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2013.

catasys inc (CATS) Key Developments

Catasys, Inc. and Health Alliance Medical Plan Announce a Multi-Year Agreement to Offer Catasys' OnTrak Program

Catasys, Inc. and Health Alliance Medical Plan announced a multi-year agreement to offer Catasys' OnTrak Program to Health Alliance members in need in Illinois. OnTrak provides support and guidance to commercial, Medicaid and Medicare Advantage members struggling with both medical and behavioral conditions. The 52-week program will be available to Health Alliance members who qualify starting this spring.

Catasys, Inc. Reports Earnings Results for the Year Ended December 31, 2014

Catasys, Inc. reported earnings results for the year ended December 31, 2014. For the year, the company’s total revenues increased 169% to $2.0 million compared with $0.75 million for the full year 2013. Total revenue increases were driven by increase in contracts in health plans covered and enrollment growth. The company reported a loss from operations before income taxes of $27.1 million, or $1.21 per basic share and per diluted share, for the full year ended December 31, 2014, compared with a loss from operations before income taxes of $2.9 million, or $0.20 per basic share and per diluted share, for the prior year 2013, related to the revaluation of the Company's warrant liabilities. The loss from operations during the full year 2014 was the result of the change in fair value of the warrants at December 31, 2014.

Catasys, Inc. Auditor Raises 'Going Concern' Doubt

Catasys, Inc. filed its 10-K on Mar 31, 2015 for the period ending Dec 31, 2014. In this report its auditor, Rose, Snyder & Jacobs, gave an unqualified opinion expressing doubt that the company can continue as a going concern.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CATS:US $1.95 USD -0.05

CATS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CATS.
View Industry Companies

Industry Analysis


Industry Average

Valuation CATS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATASYS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at